NEW YORK, March 30, 2021 (GLOBE NEWSWIRE) -- Bionic Sight, LLC announced today that the first four patients that received BS01, an investigational gene therapy for advanced stage Retinitis Pigmentosa, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results